Trial Profile
A trial to to investigate the effect of the denosumab on renal function, PTH level and quality of life (QOL) in a period of 6 months
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 May 2016
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis
- Focus Adverse reactions
- 10 May 2016 New trial record
- 17 Apr 2016 Results presented at the 2016 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases